Surrey researchers Sign in
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, K Ewer, Pedro M Folegatti, Ciaran Gilbride, Rachel Halkerston, Jennifer Hill, Daniel Jenkin, Lisa Stockdale, …
Nature medicine, Vol.27, pp.279-288
01/02/2021
PMID: 33335322

Abstract

Adolescent Adult Antibodies, Neutralizing - immunology Antibody Formation - immunology COVID-19 - immunology COVID-19 Vaccines - immunology Dose-Response Relationship, Drug Genetic Vectors - immunology Humans Immunization, Secondary Middle Aged SARS-CoV-2 - immunology Spike Glycoprotein, Coronavirus - immunology Time Factors Young Adult
url
https://doi.org/10.1038/s41591-020-01179-4View
Published (Version of record)

Details

Usage Policy